Published
Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction
Published in October 2025 Issue 10 (Vol. 13, Issue 10, 2025)
Abstract
ABSTRACTDapagliflozin is an SGLT2 inhibitor that is used to treat type 2 diabetes, as well as those with heart failure and chronic renal disease. We report a case report of a 57-year-old male diabetic who presented with severe pruritis which was later found to be due to dapagliflozin and was totally subsided after discontinuing dapagliflozin. Keyword: SGLT2 inhibitor - Selective sodium-glucose transporter-2 inhibitor.
Authors (4)
Dr. Namitha Rachel Biji
View all publications →Prof. Dr. S.K Mathew
View all publications →Dr. Dhanu Josey
View all publications →Dr. Joseph John
View all publications →Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Download Article
Best for printing and citation
File size: 0.0 MB
Format: PDF
Article Information
Published in:
October 2025 Issue 10 (Vol. 13, Issue 10, 2025)AJPHR1310001
AJPHR-1310001
2025-10-01
Article Impact
Views:4,920
Downloads:2,216
scite_
Smart Citations
0Citing Publications
0Supporting
0Mentioning
0Contrasting
View Citations
See how this article has been cited at scite.ai
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
How to Cite
Rachel, D., & Prof. Dr. S.K Mathew & Dhanu, D. & Joseph, D. (2025). Dapagliflozin Induced Severe Pruritis – A Rare Adverse Drug Reaction. American Journal of Pharmacy and Health Research, 13(10), xx-xx. DOI:https://doi.org/10.5281/zenodo.17875587